ethosuximide has been researched along with Pain, Chronic in 3 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It is the first clinical trial evaluating the efficacy and safety of ethosuximide on abdominal pain related to IBS." | 9.24 | Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial. ( Ardid, D; Dapoigny, M; Kerckhove, N; Pereira, B; Scanzi, J, 2017) |
| "Chronic pain is a heavy burden disease." | 5.51 | Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors. ( Boudieu, L; Bourdier, J; Daulhac, L; Eschalier, A; Kerckhove, N; Mallet, C; Ourties, G, 2019) |
| " Ethosuximide (ETX), an anticonvulsant and a T-type channel blocker has shown analgesic effect in several chronic pain models but has not yet been evaluated in patients with neuropathic pain." | 5.27 | Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. ( Alchaar, H; Arcagni, P; Balp, L; Bernard, L; Bozzolo, E; Brosse, C; Creach, C; Delage, N; Delbrouck, D; Deleens, R; Duale, C; Dubray, C; Eschalier, A; Gillet, D; Gov, C; Hamdani, A; Hieng, VS; Kerckhove, N; Kuhn, E; Lambert, C; Lanteri-Minet, M; Lefebvre-Kuntz, D; Leroux-Bromberg, N; Letellier, M; Lietar, B; Lucas, C; Maindet, C; Mallet, C; Marcaillou, F; Martinez, V; Mick, G; Navez, M; Pereira, B; Perier, Y; Picard, P; Piquet, E; Richard, D; Romettino, S; Serra, E; Soriot-Thomas, S; Vergne-Salle, P, 2018) |
| " It is the first clinical trial evaluating the efficacy and safety of ethosuximide on abdominal pain related to IBS." | 5.24 | Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial. ( Ardid, D; Dapoigny, M; Kerckhove, N; Pereira, B; Scanzi, J, 2017) |
| "Chronic pain is a heavy burden disease." | 1.51 | Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors. ( Boudieu, L; Bourdier, J; Daulhac, L; Eschalier, A; Kerckhove, N; Mallet, C; Ourties, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerckhove, N | 3 |
| Boudieu, L | 1 |
| Ourties, G | 1 |
| Bourdier, J | 1 |
| Daulhac, L | 1 |
| Eschalier, A | 2 |
| Mallet, C | 2 |
| Scanzi, J | 1 |
| Pereira, B | 2 |
| Ardid, D | 1 |
| Dapoigny, M | 1 |
| Soriot-Thomas, S | 1 |
| Alchaar, H | 1 |
| Deleens, R | 1 |
| Hieng, VS | 1 |
| Serra, E | 1 |
| Lanteri-Minet, M | 1 |
| Arcagni, P | 1 |
| Picard, P | 1 |
| Lefebvre-Kuntz, D | 1 |
| Maindet, C | 1 |
| Mick, G | 1 |
| Balp, L | 1 |
| Lucas, C | 1 |
| Creach, C | 1 |
| Letellier, M | 1 |
| Martinez, V | 1 |
| Navez, M | 1 |
| Delbrouck, D | 1 |
| Kuhn, E | 1 |
| Piquet, E | 1 |
| Bozzolo, E | 1 |
| Brosse, C | 1 |
| Lietar, B | 1 |
| Marcaillou, F | 1 |
| Hamdani, A | 1 |
| Leroux-Bromberg, N | 1 |
| Perier, Y | 1 |
| Vergne-Salle, P | 1 |
| Gov, C | 1 |
| Delage, N | 1 |
| Gillet, D | 1 |
| Romettino, S | 1 |
| Richard, D | 1 |
| Bernard, L | 1 |
| Lambert, C | 1 |
| Dubray, C | 1 |
| Duale, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Tolerance of Ethosuximide in the Treatment of Abdominal Pain Associated With Irritable Bowel Syndrome[NCT02973542] | Phase 2 | 162 participants (Actual) | Interventional | 2018-04-30 | Active, not recruiting | ||
| Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.[NCT02100046] | Phase 2 | 114 participants (Actual) | Interventional | 2014-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ethosuximide and Pain, Chronic
| Article | Year |
|---|---|
Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.
Topics: Abdominal Pain; Chronic Pain; Double-Blind Method; Ethosuximide; France; Humans; Irritable Bowel Syn | 2017 |
Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.
Topics: Adult; Aged; Analgesics; Anticonvulsants; Calcium Channel Blockers; Chronic Pain; Double-Blind Metho | 2018 |
1 other study available for ethosuximide and Pain, Chronic
| Article | Year |
|---|---|
Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors.
Topics: Animals; Anticonvulsants; Anxiety; Calcium Channel Blockers; Calcium Channels, T-Type; Chronic Pain; | 2019 |